Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
Early outcomes suggest that the Myval Octacor THV is a safe and effective option for TAVI in severe AS; however, larger studies with longer follow-up are required.
Authors
- Jovan Petrović (ORCID: https://orcid.org/0000-0002-9032-6228)
- Ida Subotić
- Miloš Babić (ORCID: https://orcid.org/0000-0002-3226-003X)
- Alfonso Ielasi (ORCID: https://orcid.org/0000-0002-5982-1669)
- Matija Furtula (ORCID: https://orcid.org/0000-0001-8929-0275)
- V Zobenica
- Milovan Bojić (ORCID: https://orcid.org/0000-0002-0051-041X)
- Valentina Balint
- Luca Testa
- Dragan Topić
- Mihajlo Farkic
- Aleksandra Nikolic
Institutions
- University of Banja Luka (BA)
- University of Belgrade (RS)
- IRCCS Policlinico San Donato (IT)
- Institute for Cardiovascular Diseases of Vojvodina (RS)
Publication Details
- Journal
- The Journal of invasive cardiology/The journal of invasive cardiology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.25270/jic/25.00264
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00